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Abstract
Background: Mild therapeutic hypothermia following cardiac arrest is neuroprotective, but its effect on myocardial
dysfunction that is a critical issue following resuscitation is not clear. This study sought to examine whether hypothermia
and the combination of hypothermia and pharmacological postconditioning are cardioprotective in a model of
cardiopulmonary resuscitation following acute myocardial ischemia.
Methodology/Principal Findings: Thirty pigs (28–34 kg) were subjected to cardiac arrest following left anterior descending
coronary artery ischemia. After 7 minutes of ventricular fibrillation and 2 minutes of basic life support, advanced cardiac life
support was started according to the current AHA guidelines. After successful return of spontaneous circulation (n=21),
coronary perfusion was reestablished after 60 minutes of occlusion, and animals were randomized to either normothermia
at 38uC, hypothermia at 33uC or hypothermia at 33uC combined with sevoflurane (each group n=7) for 24 hours. The
effects on cardiac damage especially on inflammation, apoptosis, and remodeling were studied using cellular and molecular
approaches. Five animals were sham operated. Animals treated with hypothermia had lower troponin T levels (p,0.01),
reduced infarct size (3467 versus 57612%; p,0.05) and improved left ventricular function compared to normothermia
(p,0.05). Hypothermia was associated with a reduction in: (i) immune cell infiltration, (ii) apoptosis, (iii) IL-1b and IL-6 mRNA
up-regulation, and (iv) IL-1b protein expression (p,0.05). Moreover, decreased matrix metalloproteinase-9 activity was
detected in the ischemic myocardium after treatment with mild hypothermia. Sevoflurane conferred additional protective
effects although statistic significance was not reached.
Conclusions/Significance: Hypothermia reduced myocardial damage and dysfunction after cardiopulmonary resuscitation
possible via a reduced rate of apoptosis and pro-inflammatory cytokine expression.
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Introduction
Although initial return of spontaneous circulation (ROSC) from
cardiac arrest is achieved in about 30–40% of cases, only 10–30%
of these patients admitted to the hospital will be discharged with
good outcome [1]. Organ dysfunction following successful
cardiopulmonary resuscitation (CPR) has mainly been attributed
to the so called ‘post-resuscitation disease’ [2]. Post-resuscitation
myocardial dysfunction is a critical issue, and has been reported in
45% to 60% of successfully resuscitated patients [3,4]. Mild
therapeutic hypothermia has emerged as an effective strategy to
reduce neurological impairment after successful CPR [5]. The
effects of mild hypothermia on post-resuscitation myocardial
dysfunction, however, are not clear. The mismatch between early
survival and final outcome emphasizes the importance of
standardized post-resuscitation care including hypothermia. Spe-
cifically, pharmacological postconditioning may offer an attractive
opportunity to further ameliorate damage to the myocardium in
the post-resuscitation period. While pharmacological postcondi-
tioning with volatile anesthetics may reduce myocardial injury
after acute myocardial infarction [6], its protective properties have
not yet been investigated in the context of postresuscitation care.
Because the majority of patients experience cardiac arrest due to
myocardial ischemia [4], and because this scenario has only been
considered in few animal experiments, our study is based on an
experimental porcine model of cardiac arrest following acute
coronary artery ischemia reflecting a realistic clinical setting. We
hypothesized that hypothermia attenuates myocardial injury in
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7588this model of global ischemia/reperfusion following coronary
artery occlusion. We further hypothesized that the volatile
anesthetic sevoflurane - when administered during reperfusion
after successful CPR - confers additional organ-protective effects.
Methods
The project was approved by the Animal Investigation
Committee of the University Schleswig-Holstein, Campus Kiel,
Germany, and animals were managed in accordance with the
guidelines of the University Schleswig-Holstein, Campus Kiel,
Germany, and the Utstein-style guidelines [7]. All animals
received human care in compliance with the ‘‘Guide for the Care
and Use of Laboratory Animals’’ published by the National
Institute of Health (NIH Publication No. 88.23, revised 1996).
Fully detailed methods and protocols are available in the online
supporting information files - Methods S1, Table S1 and Table S2.
Animals
Thisisanexperimentalstudyon40healthypigsaged 3–4months
of both gender, weighing 28 to 34 kg. Pigs received a total
intravenousanesthesia(TIVA;continuousinfusion of 4–8 mg/kg/h
propofol and 0.3 mg/kg/h sufentanil), and were ventilated for entire
study period. Depth of anesthesia was judged according to blood
pressure, heart rate and bispectral index (BISXP, Aspect Medical
Systems, Natick, MA). Five animals served as sham controls, which
wereanesthetizedwithTIVA and treated identicallyuntil theend of
the experiment except that neither myocardial ischemia was
induced nor CPR was performed.
Experimental protocol
The experimental time line is presented in figure 1. Thirty-five
pigs underwent acute myocardial ischemia according to the
technique as previously described [8]. Five pigs fibrillated
spontaneously following left anterior descending (LAD) coronary
artery occlusion that were excluded from further analysis. Thirty
pigs were subjected to cardiac arrest twenty minutes after LAD
occlusion. Ventricular fibrillation was electrically-induced by an
alternating current of 5 to 10 V in a standardized manner, and
mechanical ventilation was discontinued. After a 7-minutes non-
intervention interval of untreated ventricular fibrillation, basic life
support-CPR was simulated for 2 minutes applying external
manual chest compressions at a rate of 100 per minute, and a
compression-to-ventilation ratio of 30:2. Subsequently, advanced
cardiac life support was started according to the current AHA
guidelines. ROSC was defined as maintenance of an unassisted
pulse and a systolic aortic blood pressure of $60 mm Hg lasting
for ten consecutive minutes according to the Utstein-style
guidelines [7]. Coronary perfusion was re-established after 60
minutes of occlusion. After ROSC, animals were randomized
either to normothermia (38uC) plus TIVA (NT), hypothermia
(33uC) plus TIVA (HT), or hypothermia (33uC) combined with
sevoflurane at 1.0 MAC (2.0 Vol % end-tidal) (HT+SEV). Since
hypothermia was shown to increase blood concentrations of
propofol by about 30% [9], we reduced continuous infusion of
propofol during hypothermia targeting bispectral index values
below 60. Body core temperature was monitored continuously by
the arterial catheter, and normothermic body temperature was
maintained at 38.0uC with a heating blanket. Hypothermia was
induced by a cooling device (Icy catheter and CoolGard 3000;
Alsius Corp, Irvine, USA) that was introduced into the femoral
vein. According to the landmark study by Bernard et al. [10] we
used a target body temperature of 33uC for 12 hours. Thereafter,
rewarming was initiated (0.5uC per hour). During the post-
resuscitation period, animals received crystalloid infusions to keep
central venous pressure above 8 mm Hg and mean arterial blood
pressure above 50 mm Hg. If this first step failed, additional
norepinephrine was administered to keep mean arterial blood
Figure 1. Experimental time line. Thirty pigs were subjected to cardiac arrest following left anterior descending (LAD) coronary artery ischemia.
After 7 minutes of ventricular fibrillation (VF), pigs were resuscitated (CPR). After successful return of spontaneous circulation (ROSC; n=21), coronary
perfusion was reestablished after 60 minutes of occlusion, and animals were randomized either to normothermia at 38uC, hypothermia at 33uCo r
hypothermia at 33uC combined with sevoflurane (each group n=7) for 24 hours. Five animals were sham operated. cTnT indicates cardiac troponin T;
TEE, transesophageal echocardiography.
doi:10.1371/journal.pone.0007588.g001
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levels less than 150 mg/dL by intermittent insulin bolus
administration. Animals were killed by an overdose of sufentanil,
propofol and potassium chloride 24 hours after ROSC, and tissue
samples of the ischemic and non-ischemic myocardium were
collected and then both snap-frozen in liquid nitrogen (stored at
280uC) and fixed in 4% formaldehyde solution followed by
embedding into paraffin blocks, respectively.
Echocardiography and hemodynamics
Two-dimensional and pulsed-waved Doppler transesophageal
echocardiography (TEE) was performed by a single experienced
examiner using a Vivid i- Cardiovascular Ultrasound System (GE
Healtcare, Munich, Germany) with an omniplane TEE probe as
described before [11]. Hemodynamic data were determined at
baseline and repetitively up to 24 hours after ROSC.
Assessment of infarct size
Myocardial infarct size was determined 24 hours after ROSC as
previously described [8]. In addition, blood samples were collected
at baseline and repetitively up to 24 hours after ROSC to
determine cardiac troponin T (cTnT).
Histology and apoptosis
Paraffin-embedded slides of ischemic myocardium were stained
with hematoxylin and eosin. Caspases are proteases involved in
the apoptotic and inflammatory cascade, and in particular, caspase
3 is a central mediator of the apoptotic cascade [12]. To quantify
apoptosis, we determined uncleaved procaspase 3 by western
blotting in a first step, and performed immune fluorescence in a
second step to depict active caspase 3 in the ischemic myocardial
tissue.
Myeloperoxidase assay
Myeloperoxidase, an enzyme present in leukocytes, is an index
of tissue immune cell infiltration and was determined in ischemic
and non-ischemic myocardial tissue samples as previously
described [13].
Quantitative real-time RT-PCR
Transcript levels of the cytokines interleukin (IL)-1b, IL-6, IL-
10, tumor necrosis factor-a and intercellular adhesion molecule-1
were investigated in both ischemic and non-ischemic myocardium
and compared with sham control animals.
Enzyme-linked immunosorbent assay (ELISA)
Protein concentrations of IL-1b were determined by a swine
specific ELISA (BioSource International, Inc. Camarillo, USA) in
homogenates of frozen tissues according to the manufacturer’s
protocol. All experiments were carried out in duplicates.
Gelatine zymography- activity of MMP-9 and MMP-2
Matrix metalloproteinases (MMPs) are typical enzymes involved
in myocardial remodeling. To investigate the activity of MMP-9
and MMP-2 in ischemic and non-ischemic myocardial tissue,
gelatine zymography employing myocardial tissue was performed
as described previously [14].
In-vitro cell culture experiments
To evaluate the regulatory effects of IL-1b on MMPs activity
and cell proliferation - two major events in tissue remodeling – we
used the well characterized human fibroblast cell line HT-1080
[15] for further in-vitro cell culture experiments.
Statistical analysis
Sample size was calculated based on a previous investigation [8]
to detect a reduction in myocardial infarct size of about 50%. For
an a of 0.05 and a power of 80%, we calculated a sample size of 5
animals in each group. To account for animals who did not
achieve ROSC or died during the postresuscitation period, we
used 10 animals per group for LAD occlusion and CPR. Statistics
were performed using commercially available statistics software
(GraphPad Prism version 5.02 for Windows, GraphPad Software,
San Diego, CA). Survival rates were compared using Fisher’s exact
test. Date were analyzed by one-way repeated measures analysis of
variance (ANOVA), and in cases where significant differences
were observed, adjusted for multiple comparisons (Bonferroni).
Variables are expressed as mean 6 SD or scatter plots unless
otherwise specified. Statistical significance was considered at a
two-sided p value of #0.05.
Results
Survival of animals
Twenty-one animals were successfully resuscitated. Detailed
resuscitation data are presented in table 1. In the NT group, 5 out
of 7 animals survived for 24 hours compared to all animals in the
HT and HT+SEV group (p=0.46 vs. NT). Two animals of the
NT-group died due to hemodynamic instability during the post-
resuscitation period.
Myocardial damage
Figure 2A depicts corresponding images of staining to
determine ischemic (AAR), non-ischemic (AANR), and infarcted
myocardium after 24 hours. The AAR did not differ between
groups. Infarct size was 57612% in the NT group. HT and
HT+SEV significantly reduced infarct size to 3467% and
35613%, respectively (p,0.05; Figure 2B). Animals treated with
HT had significantly lower peak serum levels of cTnT
(3.663.3 pg/mL) compared with the NT group (7.864.5 pg/
mL; p,0.01). HT+SEV further attenuated peak serum cTnT
Table 1. Cardiopulmonary resuscitation data.
NT HT HT+SEV p values
ROSC rate [n] 7/10 7/10 7/10 -
CPR time to successful
resuscitation [min]
9.762.8 10.363.4 10.563.1 0.939
Cumulative epinephrine dose
[mg/kg]
100644 101647 93633 0.828
Cumulative vasopressin dose
[IU/kg]
0.860.2 0.860.3 0.860.3 0.897
Cumulative defibrillation
energy [J]
7556420 7036413 7956199 0.854
CorPP 10 [mm Hg] 31692 6 611 28660 . 5 5 9
CorPP 15 [mm Hg] 39628 40625 38624 0.890
Time to target temperature
33uC [min]
-4 7 610 45615 -
Return of spontaneous circulation (ROSC), cardiopulmonary resuscitation (CPR)
time to successful resuscitation, cumulative epinephrine and vasopressin dose,
cumulative defibrillation energy, coronary perfusion pressure (CorPP) 10 and 15
minutes after induction of ventricular fibrillation, and induction time to target
temperature of 33uC. NT indicates normothermia; HT, hypothermia; HT+SEV,
hypothermia combined with sevoflurane. Data are mean6SD.
doi:10.1371/journal.pone.0007588.t001
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pared to HT (Figure 2C).
Echocardiography and hemodynamics
Analysis of TEE data revealed impaired left ventricular ejection
fraction (p,0.05), fractional shortening (p,0.05), E/A ratio
(p,0.01) and myocardial performance index (p,0.05) before
cardiac arrest as a result of acute LAD occlusion. While myocardial
function remained impaired compared to BL in the NT group
(p,0.05), echocardiographic variables reached baseline values in
the HT and HT+SEV group 24 hours after ROSC, respectively,
and were significantly improved compared to NT (p,0.05 vs. NT,
Figure 3). Further systemic hemodynamic variables are presented in
table 2. Heart rate, mean arterial blood pressure and cardiac index
did not significantly differ between groups corrected for repeated
time measurements defining statistical significance at a p value of
#0.007. Cumulative crystalloid fluid load and cumulative norepi-
nephrine dose were not significantly different between groups
24 hours after ROSC [NT (volume load (p=0.540);
norepinephrine dose (p=0.812): 424161244 mL; 4.461.6 mg),
HT (39876932 mL; 4.962.1 mg), HT+SEV (462761056 mL;
5.161.8 mg)].
Infiltration of immune cells and apoptosis
HT and HT+SEV animals exhibited reduced infiltration of
immune cells in the ischemic myocardium (Figure 4A). MPO
activity in ischemic tissue (AAR) was significantly decreased in the
HT (80650 mU/mg) and HT+SEV group (40640 mU/mg)
compared to the NT group (190680 mU/mg; p,0.05), confirm-
ing the morphological results (Figure 4B). Procaspase 3 was most
markedly decreased in the NT group (0.6260.08 a.u.) compared
to sham control (1.2560.18 a.u.) indicating cleavage of inactive
procaspase 3 to caspase 3 (p,0.001; Figure 4C, D). To confirm
results of western blotting we used immune fluorescence in a
second step to depict active caspase 3 that was clearly attenuated
in the HT and HT+SEV group compared to NT (Figure 4E).
Myocardial inflammation
NT resulted in a significant 42629-fold increase of IL-1b and
93634-fold increase of IL-6 mRNA-levels in ischemic myocardial
tissue (AAR) compared with sham control (p,0.01). HT and
HT+SEV significantly reduced up-regulation of IL-1b (HT 1162-
fold; HT+SEV 963-fold; p,0.05) and IL-6 mRNA-levels (HT
57616-fold; HT+SEV 39621-fold; p,0.05; Figure 5A). Com-
paring ischemic (AAR) with non-ischemic myocardial tissue
(AANR), NT resulted in a significant up-regulation of IL-1b
(36622-fold) and IL-6 (2968-fold) mRNA-levels (p,0.01) that
was significantly attenuated by HT and HT+SEV for IL-1b (HT
19611-fold; HT+SEV 1364-fold) and IL-6 mRNA-levels (HT
2669-fold; HT+SEV 1068-fold; p,0.05; Figure 5B). IL-1b
protein concentration was decreased in the HT (0.2160.06 pg/
mg) and HT+SEV group (0.1860.05 pg/mg) compared to the NT
group (0.2560.06 pg/mg protein; p,0.05 NT versus HT+SEV;
Figure 5C).
Myocardial MMP-9 and MMP-2 activity
HT and HT+SEV significantly reduced MMP-9 activity
compared to NT (HT p,0.001; HT+SEV p,0.05), however,
HT+SEV was not superior to HT alone (Figure 6A and B).
Although HT and HT+SEV tended to regulate individual MMP-2
activity, this tendency could not be confirmed by densitometry
employing higher numbers of animals per group (Figure 6C).
Discussion
Circulatory failure and myocardial dysfunction resulting from
cardiac arrest largely contribute to morbidity and mortality after
initially successful CPR [16]. We showed that (i) mild hypothermia
reduced myocardial damage and dysfunction after CPR and
myocardial ischemia most probably due to attenuation of immune
cell infiltration, apoptosis and pro-inflammatory cytokine expres-
Figure 2. Myocardial damage. A) Evans blue (EB) staining to
determine the area at risk (AAR; three images in the top row,
corresponding to pigs subjected to normothermia (NT), hypothermia
(HT), or hypothermia and sevoflurane (HT+SEV), respectively). AAR was
subjected to triphenyltetrazolium chloride (TTC) staining to determine
infarct size (corresponding images in the lower row). B) AAR expressed
as percentage of left ventricle (LV). Infarct size expressed as percentage
of the AAR. Data are expressed as dot plots and mean. C) Serum cardiac
troponin T (cTnT) release at baseline (BL), after return of spontaneous
circulation (ROSC) and 1, 3, 5, 7, 13 and 24 hours after ROSC. Data are
expressed as mean 6 SD. 1p,0.05, #p,0.01 vs. NT.
doi:10.1371/journal.pone.0007588.g002
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may confer additional protective effects on myocardium.
Coronary heart disease including acute myocardial ischemia is
the major cause of out-of-hospital cardiac arrest [4,17]. To the
best of our knowledge, however, there have only been a few
animal studies considering this complex scenario of myocardial
ischemia as the predecessor to cardiac arrest [18,19]. Therefore,
we established a porcine model of cardiac arrest following
myocardial ischemia with prearrest impaired left ventricular
function to mimic a realistic scenario of out-of-hospital cardiac
arrest. Prearrest impaired cardiac function due to acute myocar-
dial ischemia has been found to result in a substantially worse
survival compared with prearrest normal cardiac function [3].
Effects of hypothermia on myocardial damage and
function
From our data, we conclude that HT initiated after ROSC
reduced myocardial damage compared to NT. Analysis of
echocardiographic variables revealed a deterioration of left
ventricular function due to LAD occlusion before cardiac arrest,
that remained declined in the NT group in the post-resuscitation
period, but improved in the HT group 24 hours after ROSC,
respectively. The difference in survival found - although not
statistically significant possibly due to an inadequate sample size -
may be rooted in this improved myocardial function. Following
two underlying mechanisms may be considered: i) amelioration of
post-resuscitation myocardial stunning by hypothermia that has
recently been demonstrated in a porcine model of non-infarct
cardiac arrest [20], and ii) myocardial infarct sparing effects by
hypothermia that has also been noted [21].
In terms of available clinical evidence, mild hypothermia may
be a promising new therapeutic strategy to prevent myocardial
reperfusion injury after cardiac arrest in the post-resuscitation
period. Its use in daily clinical routine, however, is controversial at
present [22]. Very recently, a retrospective subgroup analysis of
the ‘Hypothermia after Cardiac Arrest’ trial revealed a favorable
trend for early cooling in patients with cardiac arrest following
myocardial ischemia [23]. Further, Wolfrum et al. demonstrated
that the combination of rapid induction of mild hypothermia and
percutaneous coronary intervention is feasible, safe, and beneficial
after cardiac arrest, in particular in patients with acute myocardial
ischemia [24]. In contrast, clinical studies of therapeutic
hypothermia in patients with myocardial infarction but without
cardiac arrest have not shown any beneficial effects [25,26].
Obviously, the effects of mild hypothermia may differ between
patients who had undergone resuscitation and patients with
myocardial ischemia but without cardiac arrest.
In our experimental study, HT reduced immune cell accumu-
lation and decreased myocardial apoptosis by reduced cleavage of
procaspase 3 to active caspase 3 in the ischemic myocardium
Figure 3. Transesophageal echocardiography. A) Left ventricular ejection fraction, B) fractional shortening, C) E/A ratio and D) myocardial
performance index at baseline (BL), after left anterior descending (LAD) coronary artery occlusion, and 24 hours after return of spontaneous
circulation in the normothermia (NT), hypothermia (HT) and hypothermia and sevoflurane (HT+SEV) group. *p,0.05, {p,0.01, {p,0.001 vs. baseline;
1p,0.05, #p,0.01 vs. NT.
doi:10.1371/journal.pone.0007588.g003
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attenuated up-regulation of IL-1b and IL-6 mRNA expression, and
reduced IL-1b protein expression in ischemic myocardial tissue.
Interestingly, IL-6 production is associated with negative inotropic
effects and myocardial dysfunction that may be related to enhanced
production of nitric oxide [27]. The key factors of myocardial
ischemia/reperfusion injury are accumulation of neutrophils and
the release of various inflammatory cytokines that are generated
locally in the heart and contribute to up-regulation of cell-adhesion
molecules, cardiac functional depression and apoptosis [28].
After substantial myocardial ischemia, major tissue remodeling
occurs aiming to restore the structural architecture and cardiac
function. These remodeling events go in parallel with an increased
expression and activity of MMPs in the post-infarcted myocardium
[29]. Regarding the effect of hypothermia on myocardial tissue
remodeling, we found that hypothermia reduced MMP-9 activity
in ischemic myocardial tissue, whereas the effects on MMP-2
activity were indistinguishable. Since IL-1b and other pro-
inflammatory cytokines may also be actively involved in the
regulation of matrix remodeling processes after myocardial
ischemia [30], the issue of tissue remodeling and the regulatory
effect of IL-1b on MMPs activity could be of outstanding
importance. Interestingly, preliminary in-vitro data from our group
points towards positive regulatory effects of IL-1b on MMP-2 and
MMP-9 expression and activity (Supporting information files -
Results S1 and Figure S1). Two studies further demonstrated a
central role of IL-1b as a ‘pro-fibrotic’ factor after myocardial
ischemia: (i) IL-1 receptor type 1 knockout mice showed
attenuated myocardial MMP-2 and MMP-3 expression and
decreased fibrotic remodeling [30], and (ii) administration of a
IL-1 receptor antagonist ameliorated remodeling processes in the
infarcted myocardium [31]. These data suggest that the hypo-
thermia-induced attenuation of IL-1b expression in the present
study may possibly affect cardiac MMP-2 and MMP-9 activity
facilitating tissue remodeling following CPR and myocardial
ischemia.
Additional effects of pharmacological postconditioning
Most experimental studies have documented improved func-
tional performance when organprotective agents were given before
the insult [32]. In patients with cardiac arrest, however,
pretreatment is virtually impossible because of the unpredictable
onset. Therefore, as in our study, protective interventions should
be started after the initiation of global reperfusion, when
significant damage has already occurred. In this context,
pharmacological postconditioning with volatile anesthetics in
addition to mild hypothermia - currently recommended by the
International Liaison Committee on Resuscitation for patients
with out of hospital cardiac arrest - may offer an attractive
opportunity to further ameliorate organ damage in the post-
resuscitation period. In our study, sevoflurane administered
instead of propofol during reperfusion after successful CPR tended
to further attenuate serum cTnT release, MPO activity, apoptosis
and local myocardial inflammatory response. These results,
however, did not reach statistical significance possibly due to an
inadequate sample size rather than a true difference was absent.
Zhao and coworkers demonstrated that postconditioning with
sevoflurane resulted in massive salvage of the myocardium and
reduction of infarct size by 45% [33]. Others have reported that
protective effects of sevoflurane are mediated by mitochondrial
KATP channel opening, reduction of Ca
2+-loading, and anti-
inflammatory mechanisms [34].
With respect to our experimental setting, hypothermia alone
may possess such potent organ protective properties compared to
normothermia, that an additional effect of sevoflurane could not
be revealed in the present study. Moreover, potential protective
effects of volatile anesthetics depend on energy-dependent signal
transduction, e.g. protein synthesis and phosphorylation [35], that
may be affected by hypothermia-induced decrease of global
metabolic rate as well as suppression of protein synthesis.
Limitations
Although we used a porcine model of cardiac arrest following
myocardial ischemia reflecting this common clinical scenario,
Table 2. Hemodynamic data.
NT HT HT+SEV p values
Baseline
HR, beats/minute 107621 105614 96615 0.342
MAP, mm Hg 65613 70611 71613 0.314
ETco2,m mH g 4 0 653 6 643 7 65 0.180
CI, L/min/m
2 7.461.8 6.861.3 7.461.7 0.580
Ischemia
HR, beats/minute 103614 99617 95618 0.609
MAP, mm Hg 57665 7 676 3 613 0.469
ETco2,m mH g 4 0 6634 0 633 6 65 0.050
CI, L/min/m
2 5.160.7 5.160.8 5.461.1 0.662
ROSC
HR, beats/minute 94618 99633 96621 0.988
MAP, mm Hg 55666 5 621 6068 0.225
ETco2,m mH g 3 9 694 2 643 9 67 0.363
CI, L/min/m
2 4.460.5 4.561.9 4.661.0 0.982
3 hours
HR, beats/minute 131619 147681 1 7 619 0.005
MAP, mm Hg 58665 8 665 5 66 0.799
ETco2,m mH g 3 9 653 6 643 5 64 0.080
CI, L/min/m
2 6.361.2 5.960.7 6.461.7 0.819
7 hours
HR, beats/minute 131617 140622 127620 0.821
MAP, mm Hg 58645 9 612 6168 0.820
ETco2,m mH g 3 7 673 5 643 5 62 0.731
CI, L/min/m
2 6.260.4 5.561.1 7.661.2 0.010
13 hours
HR, beats/minute 135620 121644 116617 0.627
MAP, mm Hg 53645 8 666 0 610 0.474
ETco2,m mH g 3 8 673 6 633 6 67 0.636
CI, L/min/m
2 5.760.4 5.760.4 7.061.4 0.175
24 hours
HR, beats/minute 154625 143619 124624 0.297
MAP, mm Hg 46665 7 612 5464 0.249
ETco2,m mH g 3 7 644 1 613 7 62 0.180
CI, L/min/m
2 5.660.2 7.161.6 8.761.8 0.139
Hemodynamic data were determined at baseline, after 20 minutes of coronary
occlusion (Ischemia), following return of spontaneous circulation (ROSC) and 3,
7, 13, and 24 hours after ROSC (Mean6SD). HR indicates heart rate; MAP, mean
arterial blood pressure; ETco2, end-tidal carbon dioxide, CI, cardiac index is
calculated as the ratio of cardiac output/body surface area (body surface area =
0.0734*(body weight in kg)
0.656) [36]. Considering the repeated measures factor,
statistical significance was considered at a two-sided p value of # 0.007.
doi:10.1371/journal.pone.0007588.t002
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(i) both long-term survival and neurological outcome were not
evaluated because of limitations posed by governmental regula-
tions. (ii) Induction of hypothermia has been started after
reperfusion of global ischemia but during myocardial ischemia
that may affect cardioprotective properties of hypothermia.
However, animal data [21] and subgroup analysis of human trials
[22] consistently show that hypothermia has to be induced before
myocardial reperfusion, and that the protective effect of
hypothermia is completely lost if the onset of cooling is delayed
into the myocardial reperfusion period. This may be the major
difference to global ischemia due to cardiac arrest, where
hypothermia proved to be beneficial even when induced after
the initiation of reperfusion. (iii) Blinding the investigator was not
Figure 4. Myocardial infiltration of immune cells and apoptosis. A) Representative hematoxylin and eosin staining of the ischemic
myocardium (4006magnification) corresponding to pigs subjected to normothermia (NT), hypothermia (HT), hypothermia and sevoflurane (HT+SEV)
or sham control are shown. Myocardial samples from all animals used in the study were processed for histopathological analysis. B) Quantification of
myeloperoxidase (MPO) activity in myocardial tissue for area at risk (AAR) and area at no risk (AANR). C, D) Myocardial protein expression of
procaspase-3 and b-actin were determined by western blotting from all animals used in the study. Representative blots of pigs subjected to NT, HT,
HT+SEV, and sham control are shown. E) Representative anti-caspase 3 immunfluorescence staining of the AAR (4006magnification). Data are
expressed as dot plots and mean. *p,0.05, {p,0.01 vs. Sham. 1p,0.05 vs. NT.
doi:10.1371/journal.pone.0007588.g004
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infarct size, TEE variables, and serum and tissue samples were
analyzed in a blinded fashion.
Conclusions
In conclusion, (i) hypothermia after cardiac arrest following
myocardial ischemia reduced myocardial damage, dysfunction,
apoptosis, up-regulation of inflammatory cytokines and MMP
activity in ischemic myocardium compared to NT. (ii) The
volatile anesthetic sevoflurane - when administered during
reperfusion after successful CPR - conferred additional protective
effects in the above setting without reaching statistical signifi-
cance. We suggest that sevoflurane in addition to hypothermia
may be considered as a protective intervention in the post-
resuscitation period.
Figure 5. Myocardial cytokine expression. Transcript levels of the
cardiac cytokines interleukin (IL)-1b, IL-6, IL-10, tumor necrosis factor
(TNF)-a and intercellular adhesion molecule (ICAM)-1 were determined
by quantitative RT-PCR (A, B), and protein concentrations of IL-1b were
determined by a swine specific enzyme-linked-immunosorbent assay
(C). AAR indicates area at risk; AANR, area at no risk; NT, normothermia;
HT, hypothermia; HT+SEV, hypothermia combined with sevoflurane.
Data are expressed as mean6SD (A, B) and dot plots/mean (C),
respectively. *p,0.05, {p,0.01 vs. Sham. 1p,0.05 vs. NT.
doi:10.1371/journal.pone.0007588.g005
Figure 6. Effects of hypothermia and pharmacological post-
conditioning on MMP-9 and MMP-2 activity. Activity of matrix
metalloproteinase (MMP)-9 and MMP-2 was evaluated by gelatine
zymography employing ischemic (AAR) and non-ischemic (AANR)
myocardial tissue of the same animal. A) One representative gel out
of three is shown. White bands represent areas of enzymatic activity of
MMP-9 and MMP-2, respectively. Mean intensity of the zymography
bands was normalized to sham control (dashed line) separately for
MMP-9 (B) and MMP-2 (C). AAR indicates area at risk; AANR, area at no
risk; NT, normothermia; HT, hypothermia; HT+SEV, hypothermia
combined with sevoflurane. Data are expressed as mean6SD. All
experiments were repeated three times. *p,0.001 vs. Sham, 1p,0.05,
#p,0.001 vs. NT.
doi:10.1371/journal.pone.0007588.g006
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